Patents by Inventor Sebastien Guery

Sebastien Guery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240376431
    Abstract: Provided herein, inter alia, are microbial cross-reactive antigens (mCRAGs) and compositions comprising the same for use in the stimulation of T cells for the treatment or prevention of disease associated with coronavirus infection.
    Type: Application
    Filed: September 2, 2022
    Publication date: November 14, 2024
    Inventors: Wesley William Morovic, Jonathan David Peterson, Charles Ryan Budinoff, Sebastien Guery
  • Publication number: 20240180986
    Abstract: Provided herein are compositions containing fungus, e.g., yeast, useful for treating and/or preventing gastrointestinal inflammation, and/or diseases, disorders, or conditions associated therewith, in a subject in need thereof and methods for using the same.
    Type: Application
    Filed: March 30, 2022
    Publication date: June 6, 2024
    Inventors: Patrick Boyaval, Sebastien Guery, Mathias Richard
  • Patent number: 11883446
    Abstract: This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
    Type: Grant
    Filed: April 1, 2022
    Date of Patent: January 30, 2024
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Sebastien Guery, Markus Lehtinen, Sinikka Anneli Latvala, Liisa Lehtoranta, Bryan-James Zabel, Wesley William Morovic, Charles Budinoff, Scott D. Power
  • Publication number: 20220370519
    Abstract: This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
    Type: Application
    Filed: April 1, 2022
    Publication date: November 24, 2022
    Inventors: Sebastien Guery, Markus Lehtinen, Sinikka Anneli Latvala, Liisa Lehtoranta, Bryan-James Zabel, Wesley William Morovic, Charles Budinoff, Scott D. Power
  • Patent number: 11318174
    Abstract: This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: May 3, 2022
    Inventors: Sebastien Guery, Markus Lehtinen, Sinikka Anneli Latvala, Liisa Lehtoranta, Bryan-James Zabel, Wesley William Morovic, Charles Budinoff, Scott D. Power
  • Publication number: 20220008488
    Abstract: This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.
    Type: Application
    Filed: April 26, 2021
    Publication date: January 13, 2022
    Inventors: SEBASTIEN GUERY, MARKUS LEHTINEN, SINIKKA ANNELI LATVALA, LIISA LEHTORANTA, BRYAN-JAMES Zabel, WESLEY WILLIAM MOROVIC, CHARLES BUDINOFF, SCOTT D. POWER
  • Publication number: 20100286152
    Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof,
    Type: Application
    Filed: June 5, 2008
    Publication date: November 11, 2010
    Applicant: Glaxo Group Limited
    Inventors: Giovanni Bernasconi, Steven Mark Bromidge, Andrew James Carpenter, Lucilla D'Adamo, Romano Di Fabio, Sebastien Guery, Francesca Pavone, Alfonso Pozzan, Marilisa Rinaldi, Fabio Maria Sabbatini, Yves St-Denis
  • Publication number: 20100286151
    Abstract: The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein R is an aryl or heteroaryl; which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano; Z1 is H, C1-C4 alkyl or F; Z is CH2, CH(C1-C4 alkyl), C(C1-C4 alkyl)2 or a bond; A is a 5 membered heteroaryl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, Cl C4 haloalkoxy, cyano; B is hydrogen or is a 5-6 membered heteroaryl, or phenyl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano; being A and B linked via any atom; processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, as NPY Y5 receptor antagonists and as agents for the treatment and/or prophylaxis of eating disorders such as a binge eating disorder.
    Type: Application
    Filed: January 30, 2008
    Publication date: November 11, 2010
    Inventors: Jonathan Bentley, Matteo Biagetti, Romano Di Fabio, Thorsten Genski, Sebastien Guery, Silvia Rosalia Kopf, Colin philip Leslie, Angelica Mazzali, Sergio Melotto, Domenica Antonia Pizzi, Fabio Maria Sabbatini, Catia Seri
  • Publication number: 20100179127
    Abstract: The invention relates to novel heterocyclic compounds of the formula in free base form or in acid addition salt form, in which R1, R2, R3, R4 and A are as defined in the specification, to their preparation, to their use as medicaments and to medicaments comprising them.
    Type: Application
    Filed: June 23, 2006
    Publication date: July 15, 2010
    Inventors: Philipp Floersheim, Wolfgang Froestl, Sebastien Guery, Kiemens Kaupmann, Manuel Koller
  • Publication number: 20090203705
    Abstract: The present invention relates to novel compounds of formula (I), or a pharmaceutically acceptable salt thereof, wherein R is an aryl or heteroaryl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano; Z1 is H, C1-C4 alkyl or F; Z is CH2, CH(C1-C4 alkyl), C(C1-C4 alkyl)2 or a bond; A is a 6-10 membered aryl or heteroaryl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano; or —C(?O)—X; or —O(CH2)0-1R1; B is hydrogen or is a 5-6 membered heteroaryl, or a 4-6 membered heterocycle, or phenyl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, hydroxyl, cyano; A and B being linked via any atom; R1 is —(C1-C4)alkyl(C1-C4)alkoxy; or C3-C8 cycloalkyl; or R1 is an aryl or heteroaryl, which may be substituted by one or more: halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4 haloalkyl, C1-C4 haloalkoxy, cyano; or R1 is a 4-6 membere
    Type: Application
    Filed: January 27, 2009
    Publication date: August 13, 2009
    Inventors: Matteo Biagetti, Stefania Anna Contini, Thorsten Genski, Sebastien Guery, Colin Philip Leslie, Angelica Mazzali, Domenica Antonia Pizzi, Fabio Maria Sabbatini, Catia Seri